Levetiracetam Injection is indicated as adjunctive therapy in the treatment of partial onset seizures in adults with epilepsy.
Innopharma’s levetiracetam injection is the generic version of UCB’s Keppra injection.
Furthermore, the company has signed a licensing deal with X-GEN Pharmaceuticals to market and distribute levetiracetam injection in the US.
Innopharma is engaged in developing niche generic and specialty pharmaceutical products.